The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
DiscussionThis trial is designed to examine the efficacy ofrikkunshito (TJ-43) for reducing anorexia and maintaining food intake caused by cisplatin-including chemotherapy in patients with lung cancer.Trial registrationJapan Pharmaceutical Information Center Clinical Trials Information (JAPIC CTI), trial registration: JAPICCTI-142747. Registered on 15 December 2014; the RICH trial.
Source: Trials - Category: Research Source Type: clinical trials
More News: Anorexia | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Clinical Trials | Diets | Eating Disorders & Weight Management | Gastroenterology | Lung Cancer | Nutrition | Research | Study | Weight Loss